| -0.01 / -0.29%|
The 2 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +0.29% increase from the last price of 3.49.
The current consensus among 4 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.